KR20130118890A - B형 간염의 예방 및 치료를 위한 dna 백신 조성물 - Google Patents
B형 간염의 예방 및 치료를 위한 dna 백신 조성물 Download PDFInfo
- Publication number
- KR20130118890A KR20130118890A KR1020137013827A KR20137013827A KR20130118890A KR 20130118890 A KR20130118890 A KR 20130118890A KR 1020137013827 A KR1020137013827 A KR 1020137013827A KR 20137013827 A KR20137013827 A KR 20137013827A KR 20130118890 A KR20130118890 A KR 20130118890A
- Authority
- KR
- South Korea
- Prior art keywords
- hepatitis
- plasmid
- protein
- recombinant
- vaccine composition
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2010/077979 WO2012065286A1 (zh) | 2010-11-19 | 2010-11-19 | 一种用于预防和治疗乙型肝炎的dna疫苗组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20130118890A true KR20130118890A (ko) | 2013-10-30 |
Family
ID=46083468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020137013827A KR20130118890A (ko) | 2010-11-19 | 2010-11-19 | B형 간염의 예방 및 치료를 위한 dna 백신 조성물 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2014500875A (zh) |
KR (1) | KR20130118890A (zh) |
CN (1) | CN103547286B (zh) |
WO (1) | WO2012065286A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113058033B (zh) * | 2019-12-16 | 2024-07-09 | 远大赛威信生命科学(南京)有限公司 | 一种用于预防和治疗乙型肝炎的药物组合物及其用途 |
WO2023133509A2 (en) * | 2022-01-08 | 2023-07-13 | Carogen Corporation | Multi-antigen therapeutic vaccines to treat or prevent chronic hepatitis b virus infection |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2795446B2 (ja) * | 1988-12-15 | 1998-09-10 | 第一製薬株式会社 | Hbv−dna配列および遺伝子導入動物 |
CN1200106C (zh) * | 1999-06-18 | 2005-05-04 | 中国人民解放军第四五八医院 | 抗乙型肝炎病毒双质粒基因疫苗、其制备方法及应用 |
FR2804028B1 (fr) * | 2000-01-21 | 2004-06-04 | Merial Sas | Vaccins adn ameliores pour animaux de rente |
EP2057268B1 (en) * | 2006-08-14 | 2014-08-13 | Postech Foundation | A dna vaccine for curing chronic hepatitis b and a method of preparing same |
CN101220373B (zh) * | 2007-01-10 | 2012-01-11 | 深圳市源兴生物医药科技有限公司 | 一种重组病毒载体及其应用 |
KR100836745B1 (ko) * | 2007-01-31 | 2008-06-10 | (주)두비엘 | Hbv 백신 및 그의 제조 방법 |
-
2010
- 2010-11-19 WO PCT/CN2010/077979 patent/WO2012065286A1/zh active Application Filing
- 2010-11-19 KR KR1020137013827A patent/KR20130118890A/ko not_active Application Discontinuation
- 2010-11-19 JP JP2013539108A patent/JP2014500875A/ja active Pending
- 2010-11-19 CN CN201080070257.4A patent/CN103547286B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
WO2012065286A1 (zh) | 2012-05-24 |
JP2014500875A (ja) | 2014-01-16 |
CN103547286A (zh) | 2014-01-29 |
CN103547286B (zh) | 2016-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2015263150B2 (en) | Lentiviral vectors | |
RU2650860C2 (ru) | Векторы для экспрессии простатоассоциированных антигенов | |
KR102125658B1 (ko) | 전립선 관련된 항원 및 백신 기재 면역치료 요법 | |
KR20210093862A (ko) | 유전자 요법 벡터를 제작하기 위한 조성물 및 방법 | |
CN107574156A (zh) | 类病毒组合物颗粒及其使用方法 | |
US20220090136A1 (en) | Sin nombre virus full-length m segment-based dna vaccines | |
KR20200066349A (ko) | 복제 가능 아데노바이러스 벡터 | |
CN116322760A (zh) | 冠状病毒抗原组合物及其用途 | |
CN106536722B (zh) | 用于快速制备感染性rna病毒的方法 | |
CN102329784A (zh) | 一种日本乙型脑炎病毒样颗粒及其制备方法和应用 | |
KR20220056241A (ko) | 조류 병원체의 항원을 발현하는 재조합 칠면조 헤르페스바이러스 벡터 및 이의 용도 | |
US20040053216A1 (en) | DNA vaccines against hantavirus infections | |
KR101077330B1 (ko) | 한타 바이러스 감염에 대한 dna 백신 | |
CN104587490A (zh) | 治疗性hbv微环dna疫苗及其制备方法 | |
CN109402071A (zh) | 一种表达h9n2亚型禽流感病毒h9蛋白的重组火鸡疱疹病毒 | |
KR20130118890A (ko) | B형 간염의 예방 및 치료를 위한 dna 백신 조성물 | |
CN114196639B (zh) | 表达3型鸭甲型肝炎病毒p1和3c基因的重组鸭瘟病毒及其构建方法和用途 | |
CN102233136B (zh) | 一种用于***的重组质粒疫苗及其组合物 | |
CN114517205A (zh) | 融合基因及一种重组新型冠状病毒高效免疫鼎分子dna疫苗及其构建方法和应用 | |
CN113462700B (zh) | SARS-CoV-2线性DNA疫苗 | |
CN102233137A (zh) | 一种用于治疗乙型肝炎的重组质粒dna疫苗组合物 | |
KR20220072758A (ko) | 트랜스-스플라이싱 아데노-연관 바이러스 벡터를 포함하는 프라임에디팅용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |